4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000018
CEO bought 21,000 shares at an average $0.02 ($413)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-08 | Purchase : show line 1 in the form | +2,000 | $0.02 | $39 | 21,795,123 | D |
| 2019-03-08 | Purchase : show line 2 in the form | +5,000 | $0.02 | $105 | 21,800,123 | D |
| 2019-03-11 | Purchase : show line 3 in the form | +500 | $0.02 | $10 | 21,800,623 | D |
| 2019-03-11 | Purchase : show line 4 in the form | +2,000 | $0.02 | $38 | 21,802,623 | D |
| 2019-03-11 | Purchase : show line 5 in the form | +500 | $0.02 | $10 | 21,803,123 | D |
| 2019-03-11 | Purchase : show line 6 in the form | +2,000 | $0.02 | $38 | 21,805,123 | D |
| 2019-03-11 | Purchase : show line 7 in the form | +2,000 | $0.02 | $38 | 21,807,123 | D |
| 2019-03-11 | Purchase : show line 8 in the form | +5,000 | $0.02 | $96 | 21,812,123 | D |
| 2019-03-12 | Purchase : show line 9 in the form | +2,000 | $0.02 | $39 | 21,814,123 | D |
| Open-market purchases · 21,000 sh · avg $0.02 · $413 | ||||||
Loading xslF345X03/primary_doc.xml…